Fig. 5From: Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysisCost effectiveness acceptability curve from probabilistic sensitivity analysis comparing UAPR and CIUP. UAPR has a 100% probability of being more cost effective that CIUP for willingness to pay of SGD 10,000 and aboveBack to article page